APO RESEARCH · REPORT
Drug Abuse Treatment
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
Product & engineering
Understand the product.
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
Selected research
Industry Research
Drug Abuse Treatment Industry Research Report 2026
Market perspective
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.
Report Scope
Read the full market overview
This report quantifies the global Drug Abuse Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Abuse Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Abuse Treatment Market by Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
Drug Abuse Treatment Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Drug Abuse Treatment Segment by Application
Hospital & Clinics
Residential (non-hospital)
Drug Abuse Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Abuse Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Abuse Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Abuse Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Abuse Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Opioid Addiction
- Tobacco/Nicotine Addiction
- Alcohol Dependence
Applications
- Hospital & Clinics
- Residential (non-hospital)
Companies covered
- Indivior
- Pfizer
- Alkermes
- Novartis
- Mylan
- Cipla
- Glenmark
- Dr. Reddy's Laboratories
- Teva Pharmaceutical
- PLIVA (Odyssey)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Abuse Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Opioid Addiction
- 2.2.3 Tobacco/Nicotine Addiction
- 2.2.4 Alcohol Dependence
- 2.3 Drug Abuse Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital & Clinics
- 2.3.3 Residential (non-hospital)
- 2.4 Assumptions and Limitations
3 Drug Abuse Treatment Breakdown Data by Type
- 3.1 Global Drug Abuse Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Abuse Treatment Forecasted Market Size by Type (2027-2032)
4 Drug Abuse Treatment Breakdown Data by Application
- 4.1 Global Drug Abuse Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Abuse Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Abuse Treatment Market Perspective (2021-2032)
- 5.2 Global Drug Abuse Treatment Growth Trends by Region
- 5.2.1 Global Drug Abuse Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Abuse Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Abuse Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Abuse Treatment Market Dynamics
- 5.3.1 Drug Abuse Treatment Industry Trends
- 5.3.2 Drug Abuse Treatment Market Drivers
- 5.3.3 Drug Abuse Treatment Market Challenges
- 5.3.4 Drug Abuse Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Abuse Treatment Players by Revenue
- 6.1.1 Global Top Drug Abuse Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Drug Abuse Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Abuse Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Abuse Treatment Head Office and Area Served
- 6.4 Global Drug Abuse Treatment Players, Product Type & Application
- 6.5 Global Drug Abuse Treatment Manufacturers Established Date
- 6.6 Global Drug Abuse Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Abuse Treatment Market Size (2021-2032)
- 7.2 North America Drug Abuse Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Abuse Treatment Market Size by Country (2021-2026)
- 7.4 North America Drug Abuse Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Abuse Treatment Market Size (2021-2032)
- 8.2 Europe Drug Abuse Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Abuse Treatment Market Size by Country (2021-2026)
- 8.4 Europe Drug Abuse Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Abuse Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Abuse Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Abuse Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Abuse Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Abuse Treatment Market Size (2021-2032)
- 10.2 South America Drug Abuse Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Abuse Treatment Market Size by Country (2021-2026)
- 10.4 South America Drug Abuse Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Abuse Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Abuse Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Abuse Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Abuse Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Indivior
- 12.1.1 Indivior Company Information
- 12.1.2 Indivior Business Overview
- 12.1.3 Indivior Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.1.4 Indivior Drug Abuse Treatment Product Portfolio
- 12.1.5 Indivior Recent Developments
- 12.2 Pfizer
- 12.2.1 Pfizer Company Information
- 12.2.2 Pfizer Business Overview
- 12.2.3 Pfizer Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.2.4 Pfizer Drug Abuse Treatment Product Portfolio
- 12.2.5 Pfizer Recent Developments
- 12.3 Alkermes
- 12.3.1 Alkermes Company Information
- 12.3.2 Alkermes Business Overview
- 12.3.3 Alkermes Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.3.4 Alkermes Drug Abuse Treatment Product Portfolio
- 12.3.5 Alkermes Recent Developments
- 12.4 Novartis
- 12.4.1 Novartis Company Information
- 12.4.2 Novartis Business Overview
- 12.4.3 Novartis Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.4.4 Novartis Drug Abuse Treatment Product Portfolio
- 12.4.5 Novartis Recent Developments
- 12.5 Mylan
- 12.5.1 Mylan Company Information
- 12.5.2 Mylan Business Overview
- 12.5.3 Mylan Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.5.4 Mylan Drug Abuse Treatment Product Portfolio
- 12.5.5 Mylan Recent Developments
- 12.6 Cipla
- 12.6.1 Cipla Company Information
- 12.6.2 Cipla Business Overview
- 12.6.3 Cipla Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.6.4 Cipla Drug Abuse Treatment Product Portfolio
- 12.6.5 Cipla Recent Developments
- 12.7 Glenmark
- 12.7.1 Glenmark Company Information
- 12.7.2 Glenmark Business Overview
- 12.7.3 Glenmark Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.7.4 Glenmark Drug Abuse Treatment Product Portfolio
- 12.7.5 Glenmark Recent Developments
- 12.8 Dr. Reddy's Laboratories
- 12.8.1 Dr. Reddy's Laboratories Company Information
- 12.8.2 Dr. Reddy's Laboratories Business Overview
- 12.8.3 Dr. Reddy's Laboratories Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.8.4 Dr. Reddy's Laboratories Drug Abuse Treatment Product Portfolio
- 12.8.5 Dr. Reddy's Laboratories Recent Developments
- 12.9 Teva Pharmaceutical
- 12.9.1 Teva Pharmaceutical Company Information
- 12.9.2 Teva Pharmaceutical Business Overview
- 12.9.3 Teva Pharmaceutical Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.9.4 Teva Pharmaceutical Drug Abuse Treatment Product Portfolio
- 12.9.5 Teva Pharmaceutical Recent Developments
- 12.10 PLIVA (Odyssey)
- 12.10.1 PLIVA (Odyssey) Company Information
- 12.10.2 PLIVA (Odyssey) Business Overview
- 12.10.3 PLIVA (Odyssey) Revenue in Drug Abuse Treatment Business (2021-2026)
- 12.10.4 PLIVA (Odyssey) Drug Abuse Treatment Product Portfolio
- 12.10.5 PLIVA (Odyssey) Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst